Vector Laboratories Overview
- Founded
- 1976

- Status
- Acquired/Merged
- Latest Deal Type
- Debt
- Financing Rounds
- 2
Vector Laboratories General Information
Description
Developer and manufacturer of labeling and detection reagents. The company specializes in developing labeling and detection reagents which are critical components in immunohistochemistry studies and other life science research applications, enabling researchers at leading hospitals, academic research institutions and life science companies to receive new formulations of curing antifade mounting media for immunofluorescence applications that overcome many of the issues experienced with other setting antifade media.
Contact Information
(Operating Subsidiary)
- 30 Ingold Road
- Burlingame, CA 94010
- United States
Vector Laboratories Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Vector Laboratories‘s full profile, request access.
Request a free trialVector Laboratories Comparisons
Industry
00000-00
0000 000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialVector Laboratories Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Trans-Hit Biomarkers | Corporate Backed or Acquired | Laval, Canada | 000000&0 | |||
0000 000000000 000 | Corporation | Danvers, MA | 0000000000 | |||
00 000 00000000000 | Corporate Backed or Acquired | Carlsbad, CA | 00 | 000000&0 | ||
00000 0000 0000000 | Private Equity-Backed | Irving, TX | 0000 | 00000 | 0000000 0000 | 00000 |
00000000 | Formerly VC-backed | Boulder, CO | 000 | 00000 | 00000000 | 00000 |
Vector Laboratories Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Carl Hull | Chief Executive Officer | ||
Lisa Sellers Ph.D | Chief Operating Officer |